RAPID is designed to provide physicians with fully automated and easy-to-interpret imaging that facilitates timely clinical decision-making around stroke.
“Strokes are a medical emergency, and urgent treatment is essential. The sooner a person receives treatment for a stroke, the less damage is likely to happen. That’s why Punta Mita Hospital has acquired the most advanced cerebrovascular imaging platform available, RAPID,” explains Dr. Luis Alberto López Avelar, General Director of Punta Mita Hospital. “We are committed to offering the best quality in medical care, which is why now with RAPID Punta Mita Hospital provides state-of-the-art technology for the timely and accurate diagnosis of a cerebrovascular event.”
Developed by leading stroke experts, RAPID technology has been selected for use in several ground-breaking trials that have changed treatment guidelines issued by both the American Heart Association and the American Stroke Association. The RAPID Artificial Intelligence framework combines deep learning, machine learning, and expert feature extraction. Together these provide unparalleled sensitivity and specificity across stroke modules (CT perfusion, MR diffusion and perfusion, CTA, and CT ASPECT scoring).
Results are then delivered by the RAPID Intelligence Services Platform via PACS, email, text, the RAPID app, or corporate partner workflow systems.
Since 2019, Punta Mita Hospital has been the only hospital in Mexico with this software available for any patient who needs it.
The Complete RAPID Platform includes:
- RAPID CTP: fully-automated perfusion maps; accurately quantifies reduced cerebral blood flow, cerebral blood volume and transit time
- RAPID MRI: fully-automated diffusion and perfusion maps that quantify brain areas with low ADC values, as well as delayed contrast arrival
- RAPID CTA: automatically delivers CT angiography maps and identifies brain regions with reduced blood vessel density in 2D and 3D outputs
- RAPID ASPECTS: automatically identifies areas of early ischemic change on non-contrast CT scans, which predicts irreversible injury
iSchemaView is the worldwide leader in advanced imaging for stroke. Installed in over 1,200 hospitals, iSchemaView’s RAPID (automated CTP, MR, CTA and ASPECTS), with enhanced AI framework, is the most advanced stroke imaging platform. In clinical trials, RAPID has been shown to aid in the selection of patients in early and late-window stroke trials, including SWIFT PRIME, EXTEND IA, DAWN, DEFUSE 3 and EXTEND. In addition to achieving the best clinical outcomes and largest treatment effects ever obtained, these landmark studies led to new American Heart Association and American Stroke Association guidelines and have dramatically altered the management of acute stroke around the world. For more information, visit www.RAPID.ai